Clinical Trial Update: A Study of YL242 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of YL242 in advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• YL242

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING